13 July 2022

Hogan Lovells advises on the HK$400 million IPO of Sinohealth Holdings Limited

Advising firms

5 lawyers named

Lawyer	Firm	Seniority	Practice	Office
Nelson Tang Lead	Hogan Lovells Cadwalader	Partner	Not stated	Hong Kong
Jeffrey Lee	Hogan Lovells Cadwalader	Senior associate	Not stated	Not stated
Jessica Shing	Hogan Lovells Cadwalader	Senior associate	Not stated	Not stated
Ruby Wang	Hogan Lovells Cadwalader	Other	Not stated	Not stated
Pamela Pang	Hogan Lovells Cadwalader	Other	Not stated	Not stated

2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated value: HKD 400m (HK$400 million)
What the figure measures: Issue size
Client: Not stated
Counterparties: Sinohealth Holdings Limited (Issuer)
BNP Paribas Securities (Asia) Limited (Underwriters)
CCB International Capital Limited (Underwriters)
Orient Securities (Hong Kong) Limited (Underwriters)
Haitong International Securities Company Limited (Underwriters)
UOB Kay Hian (Hong Kong) Limited (Underwriters)
Guotai Junan Securities (Hong Kong) Limited (Underwriters)
Eddid Securities and Futures Limited (Underwriters)
Zhongtai International Securities Limited (Underwriters)
Futu Securities International (Hong Kong) Limited (Underwriters)
Innovax Securities Limited (Underwriters)
Fosun Hani Securities Limited (Underwriters)
Livermore Holdings Limited (Underwriters)